bioRxivNeurosciencePreprint
Tau pathology in early Alzheimer's disease disrupts selective neurophysiological network dynamics
Ece KocagöncüiD, Andrew J. QuinniD, Azadeh FirouzianiD, Elisa CooperiD, Andrea GreveiD, Roger N. GunniD, Gary G. R. GreeniD, Mark W. WoolrichiD, Richard N. HensoniD, Simon LovestoneiD, Deep and Frequent Phenotyping study team, James Benedict RoweiD
Abstract
The role of aggregation of misfolded Tau protein in the pathogenesis of Alzheimers disease is the subject of rapid biomarker development and new therapeutic strategies to slow or prevent dementia. We tested the hypothesis that Tau pathology is associated with functional organization of widespread neurophysiological networks. We used electro-magnetoencephalography (E/MEG) in combination with [18F]AV1451 PET scanning to quantify Tau-dependent network disruption. Using a graph theoretical approach to MEG connectivity, we quantified nodal measures of functional segregation, centrality and efficiency of information transfer. We correlated these metrics against the nodes uptake of [18F]AV1451. There were both regional- and frequency-specific effects of Tau levels on the efficiency of information transfer and network segregation in early AD. Tau correlated with temporal regional participation coefficient (in delta, theta, beta bands); and temporal lobar eigenvector centrality (in theta, alpha, beta bands), but greater eccentricity at higher frequencies (gamma). The results support the translational development of neurophysiological "signatures" as biomarkers of Alzheimers disease, with potential to facilitate experimental medicines studies.
- organism: human
- assay: electronic health records
- research focus: cell-cell communication
- approach: statistical model
- Citations
- 2
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Neurophysiological signatures of default mode network dysfunction and cognitive decline in Alzheimer disease.
Recep A. Ozdemir, Brice Passera, … Mouhsin M. Shafi·bioRxiv·Sep 16, 2024
- Brain network dynamics determine tau presence while regional vulnerability governs tau load in Alzheimer's disease
Yu Xiao, Nicola Spotorno, … Jacob W. Vogel·bioRxiv·Apr 17, 2025
- Effects of Alzheimer's disease plasma marker levels on multilayer centrality in healthy individuals
Alejandra García‐Colomo, David López‐Sanz, … Fernando Maestú·Alzheimer s Research & TherapyPeer-reviewed·Jan 6, 2025
- Amyloid-β and tau pathologies relate to distinctive brain dysconnectomics in preclinical autosomal-dominant Alzheimer's disease
Edmarie Guzmán‐Vélez, Ibai Palacio Diez, … Yakeel T. Quiroz·Proceedings of the National Academy of SciencesPeer-reviewed·Apr 5, 2022
- Neurophysiological trajectories in Alzheimer's disease progression
Kiwamu Kudo, Kamalini G. Ranasinghe, … Srikantan S. Nagarajan·eLifePeer-reviewed·Oct 9, 2023
- FMRI complexity correlates with tau-PET in Late-Onset and Autosomal Dominant Alzheimer's Disease
Kay Jann, Julia Boudreau, … the Alzheimer’s Disease Neuroimaging Initiative·Journal of Alzheimer s DiseasePeer-reviewed·Aug 18, 2023